SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis
- 30 December 2008
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 105 (52), 20828-20833
- https://doi.org/10.1073/pnas.0810278105
Abstract
Despite their common ability to activate intracellular signaling through CD80/CD86 molecules, cytotoxic T lymphocyte antigen 4 (CTLA-4)-Ig and CD28-Ig bias the downstream response in opposite directions, the latter promoting immunity, and CTLA-4-Ig tolerance, in dendritic cells (DCs) with opposite but flexible programs of antigen presentation. Nevertheless, in the absence of suppressor of cytokine signaling 3 (SOCS3), CD28-Ig-and the associated, dominant IL-6 response-become immunosuppressive and mimic the effect of CTLA-4-Ig, including a high functional expression of the tolerogenic enzyme indoleamine 2,3-dioxygenase (IDO). Here we show that forced SOCS3 expression antagonized CTLA-4-Ig activity in a proteasome-dependent fashion. Unrecognized by previous studies, IDO appeared to possess two tyrosine residues within two distinct putative immunoreceptor tyrosine-based inhibitory motifs, VPY(115)CEL and LLY(253)EGV. We found that SOCS3-known to interact with phosphotyrosine-containing peptides and be selectively induced by CD28-Ig/IL-6-would bind IDO and target the IDO/SOCS3 complex for ubiquitination and subsequent proteasomal degradation. This event accounted for the ability of CD28-Ig and IL-6 to convert otherwise tolerogenic, IDO-competent DCs into immunogenic cells. Thus onset of immunity in response to antigen within an early inflammatory context requires that IDO be degraded in tolerogenic DCs. In addition to identifying SOCS3 as a candidate signature for mouse DC subsets programmed to direct immunity, this study demonstrates that IDO undergoes regulatory proteolysis in response to immunogenic stimuli.Keywords
This publication has 48 references indexed in Scilit:
- Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6The Journal of Experimental Medicine, 2008
- Cytokine Signaling Modules in Inflammatory ResponsesImmunity, 2008
- 3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosisProceedings of the National Academy of Sciences of the United States of America, 2007
- SOCS proteins, cytokine signalling and immune regulationNature Reviews Immunology, 2007
- Cooperation of Toll-like receptor signals in innate immune defenceNature Reviews Immunology, 2007
- SOCS3 Targets Siglec 7 for Proteasomal Degradation and Blocks Siglec 7-mediated ResponsesPublished by Elsevier BV ,2007
- SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritisJCI Insight, 2006
- SOCS2 Can Enhance Interleukin-2 (IL-2) and IL-3 Signaling by Accelerating SOCS3 DegradationMolecular and Cellular Biology, 2005
- Matching SOCS with functionNature Immunology, 2003
- Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?Immunology Today, 1999